WE ARE CURRENTLY STUDYING
STEM CELL THERAPIES WITH CLINIC PARTNERS
Welcome to Aristoloft, we, Aristoloft and its sister company CellularStem, and associated clinics are devoted to advancing access and quality care in the area of adult stem cell regenerative medicine in order to help people suffering from a variety of inflammatory and degenerative conditions.
We are studying the following conditions in patient funded medical procedures with informed consent of patients.
⊗ Cancer (Photodynamic Laser Therapy) Germany ONLY
⊗ Interstitial Cystitis
⊗ IVF (Northern Cyprus)
⊗ Motor Neuron Disease
⊗ Multiple Sclerosis
⊗ Optic Nerve Atrophy
⊗ Retinitis Pigmentosa
⊗ Spinal Cord Injury
Aristoloft, together with CellularStem and it’s associated treatment centers are not offering stem cell therapy as a cure for any condition, disease, or injury. No statements or implied treatments on this or other websites, Facebook pages or other social media sites of our organization have been evaluated or approved by the FDA. This website contains no medical advice.
All statements and opinions provided by this and other related company website are provided for educational and informational purposes only and we do not diagnose or treat via this website or via telephone. Aristoloft, together with CellularStem and its associated treatment centers are offering patient funded research to provide individual patients with Stem Cell Treatments from autologous and allogeneic sources as personalized surgical procedures only and are not involved in the use or manufacture of any investigational drugs.
Aristoloft with its sister company CellularStem and its associated clinic partners do not claim that any applications, or potential applications, using stem cells are approved by the FDA, or are even effective. We do not claim that these treatments work for any listed nor unlisted condition, intended or implied. It’s important for potential patients to do their own research based on the options that we present so that one can make an informed decision. Any decision to participate in our patient funded investigational protocols is completely voluntary.